ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OSIP Osi Pharmaceuticals Inc. (MM)

57.49
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Osi Pharmaceuticals Inc. (MM) NASDAQ:OSIP NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 57.49 0 01:00:00

- Statement of Beneficial Ownership (SC 13D)

12/04/2010 10:21pm

Edgar (US Regulatory)


 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

SCHEDULE 13D

Under the Securities Exchange Act of 1934*

 

 

OSI Pharmaceuticals, Inc.

(Name of issuer)

 

 

Common Stock, par value $.01 per share

(Title of class of securities)

671040103

(CUSIP number)

Adam J. Semler

York Capital Management Global Advisors, LLC

767 Fifth Avenue, 17t h Floor

New York, New York 10153

Telephone: (212) 300-1300

With copies to:

Richard P. Swanson, Esq.

Arnold & Porter LLP

399 Park Avenue

New York, New York 10022

(Name, address and telephone number of person authorized to receive notices and communications)

March 1, 2010

(Date of event which requires filing of this statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §240.13d-1(e), §240.13d-1(f) or §240.13d-1(g), check the following box.   ¨

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

 

*   The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


   13D   

 

 

CUSIP No. 671040103

  1)   

Names of reporting persons

 

JGD Management Corp.

  2)  

Check the appropriate box if a member of a group (see instructions)

(a)   ¨         (b)   x

 

  3)  

SEC use only

 

  4)  

Source of funds (see instructions)

 

    WC

  5)  

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)   ¨

 

  6)  

Citizenship or place of organization

 

    Delaware

Number of

shares

beneficially

owned by

each

reporting

person

with

     7)    

Sole voting power

 

    742,508

     8)   

Shared voting power

 

    -0-

     9)   

Sole dispositive power

 

    742,508

   10)   

Shared dispositive power

 

    -0-

11)

 

Aggregate amount beneficially owned by each reporting person

 

    742,508

12)

 

Check if the aggregate amount in Row (11) excludes certain shares of common stock (see instructions)   ¨

 

13)

 

Percent of class represented by amount in Row (11)

 

    Approximately 1.3%

14)

 

Type of reporting person (see instructions)

 

    IA, CO

 

Page 2 of 18 Pages


   13D   

 

 

CUSIP No. 671040103

  1)   

Names of reporting persons

 

York Capital Management Global Advisors, LLC

  2)  

Check the appropriate box if a member of a group (see instructions)

(a)   ¨         (b)   x

 

  3)  

SEC use only

 

  4)  

Source of funds (see instructions)

 

    WC

  5)  

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)   ¨

 

  6)  

Citizenship or place of organization

 

    New York

Number of

shares

beneficially

owned by

each

reporting

person

with

     7)    

Sole voting power

 

    4,822,092

     8)   

Shared voting power

 

    -0-

     9)   

Sole dispositive power

 

    4,822,092

   10)   

Shared dispositive power

 

    -0-

11)

 

Aggregate amount beneficially owned by each reporting person

 

    4,822,092

12)

 

Check if the aggregate amount in Row (11) excludes certain shares of common stock (see instructions)   ¨

 

13)

 

Percent of class represented by amount in Row (11)

 

    Approximately 8.3%

14)

 

Type of reporting person (see instructions)

 

    IA

 

Page 3 of 18 Pages


Item 1. Security and Issuer

This statement on Schedule 13D (this “Schedule”) relates to the common stock, par value $.01 per share (the “Common Stock”) of OSI Pharmaceuticals, Inc. (the “Company”).

The principal executive offices of the Company are located at 41 Pinelawn Road, Melville, New York 11747.

 

Item 2. Identity and Background

(a) This Statement is being filed jointly by JGD Management Corp., a Delaware corporation (“JGD”), d/b/a York Capital Management, and York Capital Management Global Advisors, LLC, a New York limited liability company (“YGA” and, together with JGD, the “Reporting Persons”) pursuant to an Agreement of Joint Filing attached hereto as Exhibit 1.

This Statement is being filed by JGD with respect to 742,508 shares of Common Stock directly owned by certain accounts (the “Managed Accounts”) managed by JGD. James G. Dinan is the sole shareholder of JGD.

This Statement is being filed by YGA with respect to:

(i) 1,094,326 shares of Common Stock directly owned by York Capital Management, L.P., a Delaware limited partnership (“York Capital”);

(ii) 1,901,341 shares of Common Stock directly owned by York Investment Master Fund, L.P., a Cayman Islands exempted limited partnership (“York Investment”);

(iii) 556,724 shares of Common Stock directly owned by York Select, L.P., a Delaware limited partnership (“York Select”);

(iv) 515,737 shares of Common Stock directly owned by York Select Master Fund, L.P., a Cayman Islands exempted limited partnership (“York Select Master”);

(v) 240,031 shares of Common Stock (which consist of (a) 224,331 shares of Common Stock and (b) options to purchase 16,700 shares of Common Stock) directly owned by York Global Value Master Fund, L.P., a Cayman Islands exempted limited partnership (“York Global Value”);

(vi) 109,000 shares of Common Stock directly owned by York Enhanced Strategies Fund, L.P., a Delaware limited partnership (“York Enhanced Strategies”);

 

Page 4 of 18 Pages


(vii) 182,325 shares of Common Stock directly owned by York Asian Opportunities Master Fund, L.P., a Cayman Islands exempted limited partnership (“York Asian Opportunities Master”);

(viii) 4,935 shares of Common Stock directly owned by York Long Enhanced Fund, L.P., a Delaware limited partnership (“York Long Enhanced”); and

(ix) 216,673 shares of Common Stock directly owned by Jorvik Multi-Strategy Master Fund, L.P., a Cayman Islands exempted limited partnership (“Jorvik”).

YGA, the sole managing member of the general partner of each of York Capital, York Investment, York Select, York Select Master, York Global Value, York Enhanced Strategies, York Asian Opportunities Master, York Long Enhanced and Jorvik, exercises investment discretion over such investment funds and accordingly may be deemed to have beneficial ownership over the shares of Common Stock directly owned by such investment funds.

James G. Dinan is the chairman and one of two senior managers of YGA. Daniel A. Schwartz is also a senior manager of YGA.

Dinan Management, L.L.C., a New York limited liability company (“Dinan Management”), is the general partner of York Capital, York Investment and Jorvik. YGA is the sole managing member of Dinan Management.

York Select Domestic Holdings, LLC, a New York limited liability company (“York Select Domestic Holdings”), is the general partner of York Select and York Select Master. YGA is the sole managing member of York Select Domestic Holdings.

York Global Value Holdings, LLC, a New York limited liability company (“York Global Value Holdings”), is the general partner of York Global Value. YGA is the sole managing member of York Global Value Holdings.

York Enhanced Strategies Management, LLC, a New York limited liability company (“York Enhanced Strategies Management”), is the general partner of York Enhanced Strategies. YGA is the sole managing member of York Enhanced Strategies Management.

York Asian Opportunities Domestic Holdings, LLC, a New York limited liability company (“York Asian Opportunities Domestic Holdings”), is the general partner of York Asian Opportunities Master. YGA is the sole managing member of York Asian Opportunities Domestic Holdings.

York Long Enhanced Domestic Holdings, LLC, a New York limited liability company (“York Long Enhanced Domestic Holdings”), is the general partner of York Long Enhanced. YGA is the sole managing member of York Long Enhanced Domestic Holdings.

 

Page 5 of 18 Pages


The name of each director and each executive officer of JGD is set forth on Exhibit 2 to this Statement, which is incorporated herein by reference.

(b) The principal business office address of each of JGD, YGA, York Capital, York Investment, York Select, York Select Master, York Global Value, York Enhanced Strategies, York Asian Opportunities Master, York Long Enhanced, Jorvik, Dinan Management, York Select Domestic Holdings, York Global Value Holdings, York Enhanced Strategies Management, York Asian Opportunities Domestic Holdings, York Long Enhanced Domestic Holdings, James G. Dinan and Daniel A. Schwartz is:

c/o York Capital Management

767 Fifth Avenue, 17th Floor

New York, New York 10153

The business address of each other person named in Item 2(a) above is set forth on Exhibit 2 to this Statement, which is incorporated herein by reference.

(c) JGD and YGA are investment managers of certain investment funds and accounts for which they have discretionary investment authority.

Each of York Capital, York Investment, York Select, York Select Master, York Global Value, York Enhanced Strategies, York Asian Opportunities Master, York Long Enhanced and Jorvik is a privately owned investment limited partnership in the principal business of purchasing for investment trading purposes securities and other financial instruments.

Dinan Management is a privately owned limited liability company in the principal business of acting as the general partner of York Capital, York Investment and Jorvik and the general partner or manager of four other private investment funds.

York Select Domestic Holdings is a privately owned limited liability company in the principal business of acting as the general partner of York Select and York Select Master and the manager of one other private investment fund.

York Global Value Holdings is a privately owned limited liability company in the principal business of acting as the general partner of York Global Value and the manager of one other private investment fund.

York Enhanced Strategies Management is a privately owned limited liability company in the principal business of acting as the general partner of York Enhanced Strategies.

 

Page 6 of 18 Pages


York Asian Opportunities Domestic Holdings is a privately owned limited liability company in the principal business of acting as the general partner of York Asian Opportunities Master and the general partner of one other private investment fund.

York Long Enhanced Domestic Holdings is a privately owned limited liability company in the principal business of acting as the general partner of York Long Enhanced.

The present principal occupation or employment of each other person named in Item 2(a) above is set forth on Exhibit 2 to this Statement, which is incorporated herein by reference.

(d)-(e) Neither the Reporting Persons nor, to the knowledge of the Reporting Persons, any other person named in Item 2(a) above has during the last five years been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

(f) The citizenship of each natural person named in Item 2(a) above is set forth on Exhibit 2 to this Statement, which is incorporated herein by reference.

 

Item 3. Source and Amount of Funds or Other Consideration

As of April 12, 2010, the aggregate amount of funds used to purchase the securities of the Company listed in Item 5(a)(i) was $311,666,588.44.

The source of the funds used by the Reporting Person for the purchase of the securities of the Company listed in Item 5(a)(i) was the respective working capital of the following advisory clients of the Reporting Persons: (i) approximately $41,598,250 of working capital of the Managed Accounts; (ii) approximately $61,261,256 of working capital of York Capital; (iii) approximately $106,442,021 of working capital of York Investment; (iv) approximately $31,167,329 of working capital of York Select; (v) approximately $28,879,771 of working capital of York Select Master; (vi) approximately $ 13,673,261 of working capital of York Global Value; (vii) approximately $6,021,999 of working capital of York Enhanced Strategies; (viii) approximately $10,212,979 of working capital of York Asian Opportunities Master; (ix) approximately $272,647 of working capital of York Long Enhanced and (x) approximately $12,137,075 of working capital of Jorvik. Working capital in each of these cases was provided by capital contributions of partners, unitholders or shareholders, as the case may be, and internally generated funds.

On March 16, 2010, YGA purchased on behalf of York Global Value options (the “Options”) to purchase 16,700 shares of Common Stock for an aggregate price of $974,243.60. The Options are currently exercisable at an exercise price of $50 per share of Common Stock. The Options terminate on April 17, 2010.

 

Page 7 of 18 Pages


Item 4. Purpose of Transaction

The Reporting Persons acquired the securities of the Company described in Item 5 of this Statement for investment purposes and not with a view towards changing or influencing control of the Company. The Company is subject to a tender offer to acquire all outstanding shares of Common Stock of the Company by Ruby Acquisition, Inc., an indirect wholly owned subsidiary of Astellas Pharma Inc., which offer commenced on March 2, 2010 (the “Tender Offer”). The Reporting Persons acquired shares of Common Stock following the public announcement of the Tender Offer and may be deemed to have acquired the shares of Common Stock in connection with the Tender Offer under interpretations of the Staff of the Securities and Exchange Commission.

The Reporting Persons reserve the right to purchase additional shares of Common Stock, either separately or together with other persons, including but not limited to pursuant to the Options, to sell all or some of the shares of Common Stock beneficially owned by them or to otherwise trade in the shares of Common Stock, in open market or private transactions, provided that in their judgment such transactions present an attractive (long- or short-term) opportunity for profit. The Reporting Persons also reserve the right to acquire or dispose of derivatives or other instruments related to shares of Common Stock or other securities of the Company, provided that in their judgment such transactions are advisable.

Except as described above, the Reporting Persons do not have any plans or proposals which relate to or would result in:

(a) the acquisition by any person of additional securities of the Company, or the disposition of securities of the Company;

(b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Company or any of its subsidiaries;

(c) a sale or transfer of a material amount of assets of the Company or any of its subsidiaries;

(d) any change in the board of directors or management of the Company, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board;

(e) any material change in the present capitalization or dividend policy of the Company;

 

Page 8 of 18 Pages


(f) any other material change in the Company’s business or corporate structure;

(g) changes in the Company’s charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Company by any person;

(h) causing a class of securities of the Company to be delisted from a national securities exchange or cease to be authorized to be quoted in an inter-dealer quotation system of registered national securities association;

(i) a class of equity securities of the Company becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Securities Exchange Act of 1934, as amended; or

(j) any action similar to those enumerated in clauses (a)-(i) above.

The Reporting Persons reserve the right to consider, either separately or together with other persons, plans or proposals relating to or resulting in the occurrence of one or more of the transactions described in clauses (a)-(j) above in the future depending upon then existing factors, including without limitation the market for the shares of Common Stock, the Company’s then prospects, alternative investment opportunities, general economic and money-market investment conditions and other factors deemed relevant from time to time.

 

Item 5. Interest in Securities of the Issuer

(a) (i) JGD may, pursuant to Rule 13d-3 of the Exchange Act, be deemed to be the beneficial owner of 742,508 shares of Common Stock, which constitute approximately 1.3% of the issued and outstanding shares of Common Stock. As the sole shareholder of JGD, James G. Dinan may be deemed to be the beneficial owner of the shares of Common Stock beneficially owned by JGD.

(ii) YGA may, pursuant to Rule 13d-3 of the Exchange Act, be deemed to be the beneficial owner of 4,822,092 shares of Common Stock (which consist of (a) 4,805,392 shares of Common Stock and (b) the Options), which constitute approximately 8.3% of the issued and outstanding shares of Common Stock.

(iii) York Capital may, pursuant to Rule 13d-3 of the Exchange Act, be deemed to be the beneficial owner of 1,094,326 shares of Common Stock, which constitute approximately 1.9% of the issued and outstanding shares of Common Stock. As the general partner of York Capital, Dinan Management may be deemed to be the beneficial owner of the shares of Common Stock beneficially owned by York Capital.

(iv) York Investment may, pursuant to Rule 13d-3 of the Exchange Act, be deemed to be the beneficial owner of 1,901,341 shares of Common Stock, which

 

Page 9 of 18 Pages


constitute approximately 3.3% of the issued and outstanding shares of Common Stock. As the general partner of York Investment, Dinan Management may be deemed to be the beneficial owner of the shares of Common Stock beneficially owned by York Investment.

(v) York Select may, pursuant to Rule 13d-3 of the Exchange Act, be deemed to be the beneficial owner of 556,724 shares of Common Stock, which constitute approximately 1.0% of the issued and outstanding shares of Common Stock. As the general partner of York Select, York Select Domestic Holdings may be deemed to be the beneficial owner of the shares of Common Stock beneficially owned by York Select.

(vi) York Select Master may, pursuant to Rule 13d-3 of the Exchange Act, be deemed to be the beneficial owner of 515,737 shares of Common Stock, which constitute approximately 0.9% of the issued and outstanding shares of Common Stock. As the general partner of York Select Master, York Select Domestic Holdings may be deemed to be the beneficial owner of the shares of Common Stock beneficially owned by York Select Master.

(vii) York Global Value may, pursuant to Rule 13d-3 of the Exchange Act, be deemed to be the beneficial owner of 240,031 shares of Common Stock (which consist of (a) 224,331 shares of Common Stock and (b) the Options), which constitute approximately 0.4% of the issued and outstanding shares of Common Stock. As the general partner of York Global Value, York Global Value Holdings may be deemed to be the beneficial owner of the shares of Common Stock beneficially owned by York Global Value.

(viii) York Enhanced Strategies may, pursuant to Rule 13d-3 of the Exchange Act, be deemed to be the beneficial owner of 109,000 shares of Common Stock, which constitute approximately 0.2% of the issued and outstanding shares of Common Stock. As the general partner of York Enhanced Strategies, York Enhanced Strategies Management may be deemed to be the beneficial owner of the shares of Common Stock beneficially owned by York Enhanced Strategies.

(ix) York Asian Opportunities Master may, pursuant to Rule 13d-3 of the Exchange Act, be deemed to be the beneficial owner of 182,325 shares of Common Stock, which constitute approximately 0.3% of the issued and outstanding shares of Common Stock. As the general partner of York Asian Opportunities Master, York Asian Opportunities Domestic Holdings may be deemed to be the beneficial owner of the shares of Common Stock beneficially owned by York Asian Opportunities Master.

(x) York Long Enhanced may, pursuant to Rule 13d-3 of the Exchange Act, be deemed to be the beneficial owner of 4,935 shares of Common Stock, which constitute approximately 0.0% of the issued and outstanding shares of Common Stock. As the general partner of York Long Enhanced, York Long Enhanced Domestic Holdings may be deemed to be the beneficial owner of the shares of Common Stock beneficially owned by York Long Enhanced.

 

Page 10 of 18 Pages


(xi) Jorvik may, pursuant to Rule 13d-3 of the Exchange Act, be deemed to be the beneficial owner of 216,673 shares of Common Stock, which constitute approximately 0.4% of the issued and outstanding shares of Common Stock. As the general partner of Jorvik, Dinan Management may be deemed to be the beneficial owner of the shares of Common Stock beneficially owned by Jorvik.

(xii) To the knowledge of the Reporting Persons, except as described above, no shares of Common Stock are beneficially owned, or may be deemed to be beneficially owned, by any of the persons named on Exhibit 2 to this Statement.

The number of shares of Common Stock beneficially owned and the percentage of outstanding shares of Common Stock represented thereby, for each person named above, have been computed in accordance with Rule 13d-3 under the Exchange Act. The percentages of ownership described above for JGD, York Capital, York Investment, York Select, York Select Master, York Enhanced Strategies, York Asian Opportunities Master, York Long Enhanced and Jorvik are based on 58,309,364 shares of Common Stock issued and outstanding as of February 15, 2010 as reported in the Company’s Annual Report on Form 10-K filed with the SEC on February 24, 2010. The percentages of ownership described above for YGA and York Global Value are based on an aggregate of 58,326,064 shares of Common Stock, which consists of (i) 58,309,364 shares of Common Stock issued and outstanding as of February 15, 2010 as reported in the Company’s Annual Report on Form 10-K filed with the SEC on February 24, 2010 and (ii) the number of shares of Common Stock issuable if all the Options directly held by York Global Value were exercised.

(b) (i) JGD may be deemed to have the sole power to dispose of, direct the disposition of, vote or direct the vote of 742,508 shares of Common Stock. As the sole shareholder of JGD, James G. Dinan may be deemed to have the sole power to dispose of, direct the disposition of, vote or direct the vote of 742,508 shares of Common Stock.

(ii) YGA may be deemed to have the sole power to dispose of, direct the disposition of, vote or direct the vote of 4,822,092 shares of Common Stock.

(iii) York Capital may be deemed to have the sole power to dispose of, direct the disposition of, vote or direct the vote of 1,094,326 shares of Common Stock. As the general partner of York Capital, Dinan Management may be deemed to have the sole power to dispose of, direct the disposition of, vote or direct the vote of 1,094,326 shares of Common Stock.

(iv) York Investment may be deemed to have the sole power to dispose of, direct the disposition of, vote or direct the vote of 1,901,341 shares of Common Stock. As the general partner of York Investment, Dinan Management may be deemed to have the sole power to dispose of, direct the disposition of, vote or direct the vote of 1,901,341 shares of Common Stock.

 

Page 11 of 18 Pages


(v) York Select may be deemed to have the sole power to dispose of, direct the disposition of, vote or direct the vote of 556,724 shares of Common Stock. As the general partner of York Select, York Select Domestic Holdings may be deemed to have the sole power to dispose of, direct the disposition of, vote or direct the vote of 556,724 shares of Common Stock.

(vi) York Select Master may be deemed to have the sole power to dispose of, direct the disposition of, vote or direct the vote of 515,737 shares of Common Stock. As the general partner of York Select Master, York Select Domestic Holdings may be deemed to have the sole power to dispose of, direct the disposition of, vote or direct the vote of 515,737 shares of Common Stock.

(vii) York Global Value may be deemed to have the sole power to dispose of, direct the disposition of, vote or direct the vote of 240,031 shares of Common Stock (which consist of (a) 224,331 shares of Common Stock and (b) options to purchase 16,700 shares of Common Stock). As the general partner of York Global Value, York Global Value Holdings be deemed to have the sole power to dispose of, direct the disposition of, vote or direct the vote of 240,031 shares of Common Stock (which consist of (a) 224,331 shares of Common Stock and (b) options to purchase 16,700 shares of Common Stock).

(viii) York Enhanced Strategies may be deemed to have the sole power to dispose of, direct the disposition of, vote or direct the vote of 109,000 shares of Common Stock. As the general partner of York Enhanced Strategies, York Enhanced Strategies Management be deemed to have the sole power to dispose of, direct the disposition of, vote or direct the vote of 109,000 shares of Common Stock.

(ix) York Asian Opportunities Master may be deemed to have the sole power to dispose of, direct the disposition of, vote or direct the vote of 182,325 shares of Common Stock. As the general partner of York Asian Opportunities Master, York Asian Opportunities Domestic Holdings be deemed to have the sole power to dispose of, direct the disposition of, vote or direct the vote of 182,325 shares of Common Stock.

(x) York Long Enhanced may be deemed to have the sole power to dispose of, direct the disposition of, vote or direct the vote of 4,935 shares of Common Stock. As the general partner of York Long Enhanced, York Long Enhanced Domestic Holdings may be deemed to have the sole power to dispose of, direct the disposition of, vote or direct the vote of 4,935 shares of Common Stock.

(xi) Jorvik may be deemed to have the sole power to dispose of, direct the disposition of, vote or direct the vote of 216,673 shares of Common Stock. As the general partner of Jorvik, Dinan Management may be deemed to have the sole power to dispose of, direct the disposition of, vote or direct the vote of 216,673 shares of Common Stock.

 

Page 12 of 18 Pages


(xii) To the knowledge of the Reporting Persons, except as described above, none of the persons named on Exhibit 2 to this Statement has, or may be deemed to have, any power to dispose of, direct the disposition of, vote or direct the vote of any shares of Common Stock.

(c) The following table sets forth all transactions with respect to the Shares effected during the past sixty (60) days by the Reporting Persons. All such transactions were effected in the open market.

 

Date of

Transaction

   No. of
Shares
   Price per
Share
(dollars)
   Total Price
(dollars)
  

Transaction

Type

3/1/2010    175,397    55.71260004    9,771,822.91    Purchase
3/1/2010    12,178    55.24769995    672,806.49    Purchase
3/1/2010    699,429    55.71260001    38,967,008.11    Purchase
3/1/2010    48,562    55.24770005    2,682,938.81    Purchase
3/1/2010    1,207,270    55.7126    67,260,150.60    Purchase
3/1/2010    83,822    55.24770001    4,630,972.71    Purchase
3/1/2010    353,492    55.7126    19,693,958.40    Purchase
3/1/2010    24,543    55.24769996    1,355,944.30    Purchase
3/1/2010    34,540    55.71259988    1,924,313.20    Purchase
3/1/2010    2,398    55.24769808    132,483.98    Purchase
3/1/2010    320,571    55.71260002    17,859,843.90    Purchase
3/1/2010    22,258    55.24770015    1,229,703.31    Purchase
3/1/2010    119,270    55.71259998    6,644,841.80    Purchase
3/1/2010    8,281    55.24769955    457,506.20    Purchase
3/1/2010    109,000    55.2477    6,021,999.30    Purchase
3/1/2010    108,476    55.71260002    6,043,480.00    Purchase
3/1/2010    7,532    55.24770048    416,125.68    Purchase
3/1/2010    4,935    55.2477001    272,647.40    Purchase
3/1/2010    57,746    55.71260001    3,217,179.80    Purchase
3/1/2010    4,009    55.24770017    221,488.03    Purchase
3/1/2010    193,206    55.71260002    10,764,008.60    Purchase
3/1/2010    13,414    55.24770016    741,092.65    Purchase
3/1/2010    130,603    55.71260002    7,276,232.70    Purchase
3/1/2010    9,068    55.2476996    500,986.14    Purchase
3/2/2010    19,345    56.45919979    1,092,203.22    Purchase
3/2/2010    45,039    56.6949002    2,553,481.61    Purchase
3/2/2010    77,143    56.45920006    4,355,432.07    Purchase
3/2/2010    179,601    56.69490003    10,182,460.74    Purchase
3/2/2010    133,155    56.45920003    7,517,824.78    Purchase
3/2/2010    310,006    56.6949    17,575,759.17    Purchase
3/2/2010    38,987    56.45919999    2,201,174.83    Purchase
3/2/2010    90,771    56.69490002    5,146,252.77    Purchase
3/2/2010    3,810    56.45919948    215,109.55    Purchase
3/2/2010    8,868    56.69489964    502,770.37    Purchase
3/2/2010    35,357    56.45919988    1,996,227.93    Purchase
3/2/2010    84,257    56.69490001    4,776,942.19    Purchase
3/2/2010    13,155    56.4592003    742,720.78    Purchase
3/2/2010    30,626    56.69490008    1,736,338.01    Purchase

 

Page 13 of 18 Pages


Date of

Transaction

   No. of
Shares
   Price per
Share
(dollars)
   Total Price
(dollars)
  

Transaction

Type

3/2/2010    21,310    56.45919991    1,203,145.55    Purchase
3/2/2010    27,855    56.69490002    1,579,236.44    Purchase
3/2/2010    6,369    56.45919925    359,588.64    Purchase
3/2/2010    14,828    56.69490019    840,671.98    Purchase
3/2/2010    11,964    56.4592001    675,477.87    Purchase
3/2/2010    49,612    56.69490002    2,812,747.38    Purchase
3/2/2010    14,405    56.45920028    813,294.78    Purchase
3/2/2010    33,537    56.69490026    1,901,376.87    Purchase
3/4/2010    6,469    56.61840006    366,264.43    Purchase
3/4/2010    38,697    56.61840013    2,190,962.23    Purchase
3/4/2010    6,276    56.61840025    355,337.08    Purchase
3/4/2010    3,737    56.61840246    211,582.97    Purchase
3/4/2010    13,780    56.61839985    780,201.55    Purchase
3/4/2010    3,542    56.61839921    200,542.37    Purchase
3/4/2010    3,414    56.6184007    193,295.22    Purchase
3/4/2010    6,247    56.61840083    353,695.15    Purchase
3/4/2010    5,544    56.61840007    313,892.41    Purchase
3/4/2010    13,294    56.61840003    752,685.01    Purchase
3/5/2010    14,783    56.56780018    836,241.79    Purchase
3/5/2010    3,951    56.7183017    224,094.01    Purchase
3/5/2010    1,547    56.72510019    87,753.73    Purchase
3/5/2010    27,983    56.56780009    1,582,936.75    Purchase
3/5/2010    16,465    56.71830003    933,866.81    Purchase
3/5/2010    6,446    56.72509929    365,649.99    Purchase
3/5/2010    130,913    56.56779999    7,405,460.40    Purchase
3/5/2010    25,997    56.71830019    1,474,505.65    Purchase
3/5/2010    10,178    56.72510022    577,348.07    Purchase
3/5/2010    31,093    56.56780015    1,758,862.61    Purchase
3/5/2010    8,309    56.71830064    471,272.36    Purchase
3/5/2010    3,253    56.72509991    184,526.75    Purchase
3/5/2010    3,052    56.56780144    172,644.93    Purchase
3/5/2010    816    56.71829657    46,282.13    Purchase
3/5/2010    319    56.72510972    18,095.31    Purchase
3/5/2010    28,803    56.56779988    1,629,322.34    Purchase
3/5/2010    7,697    56.71830064    436,560.76    Purchase
3/5/2010    3,014    56.72509954    170,969.45    Purchase
3/5/2010    10,539    56.5677996    596,168.04    Purchase
3/5/2010    2,815    56.71830195    159,662.02    Purchase
3/5/2010    1,103    56.72510426    62,567.79    Purchase
3/5/2010    10,014    56.56780008    566,469.95    Purchase
3/5/2010    2,676    56.7182997    151,778.17    Purchase
3/5/2010    1,048    56.72509542    59,447.90    Purchase
3/5/2010    5,102    56.56780086    288,608.92    Purchase
3/5/2010    1,364    56.71829912    77,363.76    Purchase
3/5/2010    534    56.72509363    30,291.20    Purchase
3/5/2010    17,072    56.56779991    965,725.48    Purchase
3/5/2010    4,562    56.71829899    258,748.88    Purchase
3/5/2010    1,786    56.72510078    101,311.03    Purchase
3/5/2010    11,493    56.5678004    650,133.73    Purchase
3/5/2010    3,071    56.71830023    174,181.90    Purchase

 

Page 14 of 18 Pages


Date of

Transaction

   No. of
Shares
   Price per
Share
(dollars)
   Total Price
(dollars)
  

Transaction

Type

3/5/2010    1,202    56.72509983    68,183.57    Purchase
3/16/2010    16,700    58.33794012    974,243.60    Option to Purchase
3/17/2010    12,900    58.0161    748,407.69    Purchase
4/7/2010    35,000    59.962    2,098,670.00    Purchase

The information provided in response to Item 3 above is incorporated herein by reference.

(d) The right to receive dividends from, or the proceeds from the sale of, all shares of Common Stock reported in this Statement as beneficially owned by each Reporting Person is held by York Capital, York Investment, York Select, York Select Master, York Global Value, York Enhanced Strategies, York Asian Opportunities Master, York Long Enhanced, Jorvik or the Managed Accounts, as the case may be, as the advisory clients of such Reporting Person. The Reporting Persons disclaim beneficial ownership of all shares of Common Stock reported in this Statement pursuant to Rule 13d-4 under the Exchange Act.

Except as set forth in this Item 5(d), to the knowledge of the Reporting Persons, no other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, any other shares of Common Stock deemed to be beneficially owned by the Reporting Persons.

(e) Not applicable.

 

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

The information provided in response to Item 3 and Item 4 above is incorporated herein by reference.

 

Item 7. Material to Be Filed as Exhibits

The exhibits listed on the Index of Exhibits of this Statement are filed herewith.

 

Page 15 of 18 Pages


SIGNATURES

After reasonable inquiry and to the best of the knowledge and belief of the undersigned Reporting Person, the undersigned Reporting Person certifies that the information set forth in this statement with respect to it is true, complete and correct.

Dated: April 12, 2010

 

JGD MANAGEMENT CORP.
By:  

/s/    A DAM J. S EMLER        

  Adam J. Semler
  Chief Operating Officer

 

Page 16 of 18 Pages


SIGNATURES

After reasonable inquiry and to the best of the knowledge and belief of the undersigned Reporting Person, the undersigned Reporting Person certifies that the information set forth in this statement with respect to it is true, complete and correct.

Dated: April 12, 2010

 

YORK CAPITAL MANAGEMENT GLOBAL ADVISORS, LLC
By:  

/s/    A DAM J. S EMLER        

  Adam J. Semler
  Chief Operating Officer

 

Page 17 of 18 Pages


INDEX OF EXHIBITS

 

Exhibit
No.

  

Description

1    Agreement of Joint Filing dated April 12, 2010 by and among JGD Management Corp. and York Capital Management Global Advisors, LLC.
2    Directors and Executive Officers of JGD Management Corp.

 

Page 18 of 18 Pages

1 Year Osi Pharmaceuticals Chart

1 Year Osi Pharmaceuticals Chart

1 Month Osi Pharmaceuticals Chart

1 Month Osi Pharmaceuticals Chart